Brind.

Onyx used LES for peripheral vasculature embolisation in a PELE trial procedure performed by Christopher Stark.

2 reports, 2 independent Updated Jun 18
Gone quiet
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Onyx used LES for peripheral vasculature embolisation in a PELE trial procedure performed by Christopher Stark.

Who's involved

What this event is mainly about
OnyxLES

Keep exploring

The entities involved

  • Onyx

    Chinese electronics company

    Nothing else this week.

  • LES

    Slovak company

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • eurweb.com
  • Medical Device NetworkFirst subject enrolled in trial of Medtronic’s liquid embolic system Medtronic has announced the first subject enrolment in the Peripheral Onyx Liquid Embolic (PELE) trial. The study aims to assess t